Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Windtree Therapeutics, Inc. - Common Stock (NQ:WINT)

1.230 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Windtree Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
Windtree Therapeutics, Inc. (NASDAQ: WINT) is a biotechnology company developing treatments for severe cardiovascular disorders. 
Via Benzinga
How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
Windtree Therapeutics, Inc. (NASDAQ: WINT) is a biotechnology company developing treatments for severe cardiovascular disorders. 
Via Benzinga
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
Via ACCESSWIRE
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
Windtree Therapeutics Inc. (NASDAQ: WINT) is looking to revolutionize acute care treatment for patients with serious conditions like acute heart failure (AHF) and cardiogenic shock (CS). 
Via Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
Via ACCESSWIRE
Why Windtree Therapeutics Stock Is Tumbling Today
Windtree Therapeutics Inc (NASDAQ: WINT) shares are plunging in early trading Thursday after the company announced the pricing of an upsized publ 
Via Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030. 
Via Benzinga
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ:WINT) Is Helping Change That
Via ACCESSWIRE
Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga. Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in... 
Via Benzinga
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology company treating late-stage acute cardiovascular disorders, is advancing its first-in-class drug for serious heart conditions. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for a look at the biggest pre-market stock movers on Tuesday morning with all the details traders need to know about! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 221 companies hit new 52-week lows. 
Via Benzinga
Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Nasdaq Down 100 Points; American Express Earnings Miss Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Thursday. The Dow traded down 0.51% to 33,725.78 while the NASDAQ fell 0.84% to 12,055.39.... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 286 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 147 stocks made new 52-week lows. 
Via Benzinga
Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday. The Dow traded down 0.26% to 33,809.22 while the NASDAQ fell 0.43% to 12,104.71. The... 
Via Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 149 stocks hit new 52-week lows. 
Via Benzinga
Why Is Bed Bath & Beyond (BBBY) Stock Down 19% Today?
Bed Bath & Beyond (BBBY) stock is sliding lower on Thursday as the retailer's shares come off of a recent meme stock rally. 
Via InvestorPlace
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market... 
Via Benzinga
Why Is Windtree Therapeutics (WINT) Stock Down 58% Today?
Windtree Therapeutics (WINT) stock is falling on Thursday after the company announced the departure of its Chairman of the Board. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 99 companies made new 52-week lows. 
Via Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Thursday, April 20, 2023: GOOGL, XPEV, ANET, MGM, WINT
Alphabet (GOOGL) - The company will report quarterly results next week on Tuesday after market close. Alphabet will kick off (along with Microsoft (MSFT), also on Tuesday afternoon) big tech 
Via Benzinga
Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with an overview of all the biggest pre-market stock movers worth watching on Thursday morning! 
Via InvestorPlace
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket
Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.